Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1423775
This article is part of the Research Topic Tertiary lymphoid structures (TLS) in the tumor immune microenvironment View all 12 articles

Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer

Provisionally accepted
Shuyue Xin Shuyue Xin 1Shuang Wen Shuang Wen 2Xiaopei He Xiaopei He 1Yulong Zhao Yulong Zhao 1Hui Zhao Hui Zhao 1*
  • 1 Second Affiliated Hospital of Dalian Medical University, Dalian, China
  • 2 Dalian Municipal Friendship Hospital, Dalian, Liaoning Province, China

The final, formatted version of the article will be published soon.

    Background: Tertiary lymphoid structures (TLS), ordered structure of tumor-infiltrating immune cells in tumor immune microenvironment (TIME), play an important role in the development and anti-tumor immunity of various cancers, including liver, colon, and gastric cancers. Previous studies have demonstrated that the presence of TLS in intra-tumoral (IT), invasive margin (IM), and peri-tumoral (PT) regions of the tumors at various maturity statuses. However, the density of TLS in different regions of non-small cell lung cancer (NSCLC) has not been extensively studied.Methods: TLS and tumor-infiltrating immune cells were assessed using immunohistochemistry (IHC) staining in 82 NSCLC patients. Tumor samples were divided into three subregions as IT, IM and PT regions, and TLS were identified as early/primary TLS (E-TLS) or secondary/follicular TLS (F-TLS). The distribution of TLS in different maturity statuses, along with their correlation with clinicopathological characteristics and prognostic value, was assessed. Nomograms were used to predict the probability of 1-, 3-, and 5-year overall survival (OS) in patients with NSCLC.The density of TLS and proportion of F-TLS in the IT region (90.2%, 0.45/mm 2 , and 61.0%, respectively) were significantly higher than those in the IM region (72.0%, 0.18 /mm 2 , and 39.0%, respectively) and PT region (67.1%, 0.16 /mm 2 , and 40.2%, respectively). A lower density of TLS, especially E-TLS in the IM region, was correlated with better prognosis in NSCLC patients. CD20+ B cells, CD3+ T cells, CD8+ cytotoxic T cells, and CD68+ macrophages were significantly overexpressed in the IM region. CD20+ B cells and CD3+ T cells in the IM region were significantly correlated with the density of E-TLS, while no statistically significant correlation was found with F-TLS. The E-TLS density in the IM region and TNM stage were independent prognostic factors for NSCLC patients. The nomogram showed good prognostic ability.Conclusions: A higher density of E-TLS in the IM region was associated with a worse prognosis in NSCLC patients, potentially due to the inhibition of TLS maturation caused by the increased density of suppressive immune cells at the tumor invasion front.

    Keywords: Tertiary Lymphoid Structures (TLS), Non-small cell lung cancer (NSCLC), prognosis, tumor immune microenvironment (TIME), nomogram

    Received: 26 Apr 2024; Accepted: 24 Jul 2024.

    Copyright: © 2024 Xin, Wen, He, Zhao and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hui Zhao, Second Affiliated Hospital of Dalian Medical University, Dalian, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.